Postoperative treatment with carvedilol, a β-adrenergic blocker, prevents paroxysmal atrial fibrillation after coronary artery bypass grafting

Circulation Journal

Volumn 72, Issue 4, 2008, Pages 588-591

  Tsuboi, Junichi ^a   Kawazoe, Kohei ^b   Izumoto, Hiroshi ^c   Okabayashi, Hitoshi ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b Kusatsu General Hospital   (Japan)

^c AKITA UNIVERSITY   (Japan)

Author keywords

adrenergic blocker; Carvedilol; Coronary artery bypass graft; Paroxysmal atrial fibrillation; Postoperative

Indexed keywords

CARVEDILOL;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE DURATION; DRUG DOSE ESCALATION; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; POSTOPERATIVE CARE; STATISTICAL SIGNIFICANCE;

ADRENERGIC BETA-ANTAGONISTS; AGED; ATRIAL FIBRILLATION; CARBAZOLES; CASE-CONTROL STUDIES; COHORT STUDIES; CORONARY ARTERY BYPASS; CORONARY STENOSIS; FEMALE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROPANOLAMINES; TIME FACTORS;

EID: 43549102618     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.72.588     Document Type: Article

References (25)

1. Katz AM. Potential deleterious effects of inotropic agents in the therapy of chronic heart failure. Circulation 1986; 73(Suppl): III-184-III-190.
2. Almassi GH, Schowalter T, Nicolosi AC, Aggarwal A, Moritz TE, Henderson WG, et al. Atrial fibrillation after cardiac surgery: A major morbid event? Ann Surgery 1997; 226: 501-511.
3. Hogue CW, Hyder ML. Atrial fibrillation after cardiac operation: Risks, mechanisms, and treatment. Ann Thorac Surg 2000; 69: 300-306.
4. Zaman AG, Archbold RA, Helft G, Paul E, Curzen N, Mills P. Atrial fibrillation after coronary bypass surgery: A model for preoperative risk stratification. Circulation 2000; 101: 1403-1406.
5. Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med 2001; 135: 1061-1073.
6. Eagle KA, Guyton RA, Davidoff R, Ewy GA, Fonger J, Gardner TJ, et al. ACC/AHA guidelines for coronary artery bypass graft surgery: Executive summary and recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1991 guidelines for coronary artery bypass graft surgery). Circulation 1999; 100: 1464-1480.
7. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-1355.
8. Feuerstein GZ, Ruffolo RR Jr. Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection. Euro Heart J 1995; 16(Supple F): 38-42.
9. Senior R, Muller-Beckmann B, DasGupta P, van der Does R, Lahiri A. Effect of carvedilol on ventricular arrhythmias. J Cardiovas Pharmacol 1992; 19: S117-S121.
10. Kalman JM, Munawar M, Howes LG, Louis WJ, Buxton BF, Gutteridge G, et al. Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg 1995; 60: 1709-1715.
11. Hashimoto K, Ilstrup DM, Schaff HV. Influence of clinical and hemodynamic variables on risk of supraventricular tachycardia after coronary artery bypass. J Thorac Cardiovasc Surg 1991; 101: 56-65.
12. Jideus L, Blomstrom P, Nilsson L, Stridsberg M, Hansell P, Blomstrom-Lundqvist C. Tachyarrhythmias and triggering factors for atrial fibrillation after coronary artery bypass operations. Ann Thorac Surg 2000; 69: 1064-1069.
13. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 1995; 60: 1709-1715.
14. Aranki SF, Shaw DP, Adams DH, Rizzo RJ, Couper GS, Vander Vliet M, et al. Predictors of atrial fibrillation after coronary artery surgery: Current trends and impact on hospital resources. Circulation 1996; 94: 390-397.
15. Leitch JW, Thomson D, Baird DK, Harris PJ. The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1990; 100: 338-342.
16. Fuller JA, Adams CG, Buxton B. Atrial fibrillation after coronary artery bypass grafting: Is it a disorder of the elderly? J Thorac Cardiovasc Surg 1989; 97: 821-825.
17. Rubin DA, Nieminski KE, Reed GE, Herman MV. Predictors, prevention, and long-term prognosis of atrial fibrillation after coronary artery bypass graft operations. J Thorac Cardiovasc Surg 1987; 94: 331-335.
18. Andrews TC, Reimold SC, Berlin JA, Antman EM. Prevention of supraventricular arrhythmias after coronary artery bypass surgery: A meta-analysis of randomized control trials. Circulation 1991; 84: 236-244.
19. Siebert J, Rogowski J, Jagielak D, Anisimowicz L, Lango R, Narkiewicz M. Atrial fibrillation after coronary artery bypass grafting without cardiopulmonary bypass. Eur J Cardiothorac Surg 2000; 17: 520-523.
20. Euc Y, Ketenci B, Ozsoy D, Camur G, Kayacioglu I, Terzi S, et al. Atrial fibrillation after surgical revascularization: Is there any difference between on-pump and off-pump? Eur J Cardiothorac Surg 2004; 26: 1120-1133.
21. Salamon T, Michler RE, Knott KM, Brown DA. Off-pump coronary artery bypass grafting does not decrease the incidence of atrial fibrillation. Ann Thorac Surg 2003; 75: 505-507.
22. Merritt JC, Niebauer M, Tarakji K, Hammer D, Mills RM. Comparison of effectiveness of carvedilol versus metoprolol or atenolol for atrial fibrillation appearing after coronary artery bypass grafting and cardiac valve operation. Am J Cardiol 2003; 92: 735-736.
23. Yue TL, McKenna PJ, Ruffolo RR Jr, Feuerstein G. Carvedilol, a new vasodilator and adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther 1992; 263: 92-98.
24. Libersa C, Caron J, Guedon-Moreau L, Adamantidis M, Nisse C. Adverse cardiovascular effects of antiarrhythmic drugs. Part II: Inotropic effects and specific pharmacokinetic properties. Therapie 1992; 47: 199-203.
25. Wilson JR. Use of antiarrhythmic drugs in patients with heart failure: Clinical efficacy, hemodynamic results, and relation to survival. Circulation 1987; 75(Suppl): IV-64-IV-73.